ANDROGEN DEPRIVATION THERAPY
Clinical trials for ANDROGEN DEPRIVATION THERAPY explained in plain language.
Never miss a new study
Get alerted when new ANDROGEN DEPRIVATION THERAPY trials appear
Sign up with your email to follow new studies for ANDROGEN DEPRIVATION THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to boost prostate cancer cure rates
Disease control Recruiting nowThis early-phase trial tests whether taking relugolix and enzalutamide together before and after radiation or surgery can improve cure rates and delay cancer progression in men with high-risk locally advanced prostate cancer. About 46 participants will receive the drug combinatio…
Matched conditions: ANDROGEN DEPRIVATION THERAPY
Phase: PHASE1 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated May 17, 2026 11:46 UTC
-
Exercise program aims to protect hearts of black prostate cancer patients
Disease control Recruiting nowThis study tests whether a 16-week exercise program designed for Black men can lower heart disease risk in those receiving hormone therapy for prostate cancer. Participants are randomly assigned to either the exercise group or usual care. The goal is to see if exercise improves h…
Matched conditions: ANDROGEN DEPRIVATION THERAPY
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 11, 2026 20:46 UTC
-
Needle this: acupuncture may cool hot flashes in men on prostate cancer hormone therapy
Symptom relief Recruiting nowThis study tests whether acupuncture can reduce hot flashes and improve sleep and quality of life in men receiving hormone therapy for prostate cancer. Twenty-four men will be randomly assigned to start acupuncture right away or after a delay, and all will receive standard lifest…
Matched conditions: ANDROGEN DEPRIVATION THERAPY
Phase: NA • Sponsor: Inova Health Care Services • Aim: Symptom relief
Last updated May 17, 2026 11:32 UTC
-
Hot flash hope: new drug tested for men on prostate cancer therapy
Symptom relief Recruiting nowThis study tests if fezolinetant, a drug used for hot flashes in women, can reduce hot flashes in men with prostate cancer who are on hormone therapy. About 60 men will take either the drug or a placebo daily for 4 weeks. Researchers will track hot flash frequency, severity, and …
Matched conditions: ANDROGEN DEPRIVATION THERAPY
Phase: PHASE2 • Sponsor: Shehzad Basaria, M.D. • Aim: Symptom relief
Last updated May 11, 2026 20:41 UTC
-
New hope for men battling hot flashes from prostate cancer treatment
Symptom relief Recruiting nowThis study tests a drug called fezolinetant to reduce hot flashes in men with prostate cancer who are on hormone therapy. Hot flashes can be bothersome and affect daily life. The drug is already approved for hot flashes in menopausal women. About 32 men will take the drug daily f…
Matched conditions: ANDROGEN DEPRIVATION THERAPY
Phase: PHASE2 • Sponsor: University of Vermont • Aim: Symptom relief
Last updated May 07, 2026 18:41 UTC